EVALUATION OF THE COST EFFECTIVENESS OF THE TREATMENT OF MILD AND MODERATE ALZHEIMER'S DISEASE

被引：0
|
作者：
Langsch, L. R. [1 ]
机构：
[1] Univ Estado Rio de Janeiro, Sao Pedro Da Aldeia, Brazil
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2479
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM9
引用
收藏
页码：A860 / A860
页数：1
相关论文
共 50 条
  • [41] The safety of combined galantamine-memantine treatment in mild to moderate Alzheimer's disease
    Ramaswamy, K.
    Amatniek, J.
    Crivera, C.
    Rupnow, M.
    Zhu, Y.
    Hammond, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 68 - 68
  • [42] Nicergoline in the treatment of mild-to-moderate Alzheimer's disease - A European multicentre trial
    Winblad, B
    Bonura, ML
    Rossini, BM
    Battaglia, A
    CLINICAL DRUG INVESTIGATION, 2001, 21 (09) : 621 - 632
  • [43] Donepezil in the treatment of mild to moderate Alzheimer's disease: report of a Belgian multicenter study
    Santens, P
    Ventura, M
    ACTA NEUROLOGICA BELGICA, 2003, 103 (03) : 159 - 163
  • [44] Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease
    Sharma, Alok
    Bemis, Marc
    Desilets, Alicia R.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2014, 29 (05): : 409 - 414
  • [45] Atorvastatin for the treatment of mild to moderate Alzheimer disease - Preliminary results
    Sparks, DL
    Sabbagh, MN
    Connor, DJ
    Lopez, J
    Launer, LJ
    Browne, P
    Wasser, D
    Johnson-Traver, S
    Lochhead, J
    Ziolwolski, C
    ARCHIVES OF NEUROLOGY, 2005, 62 (05) : 753 - 757
  • [46] Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands
    Hoogveldt, Bart
    Rive, Benoit
    Severens, Johan
    Maman, Khaled
    Guilhaume, Chantal
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 313 - 317
  • [47] COST-EFFECTIVENESS ANALYSIS OF PHARMACOLOGICAL TREATMENTS OF MODERATE-TO-SEVERE ALZHEIMER'S DISEASE
    Yunusa, I
    Rane, A.
    Sultan, I
    Eguale, T.
    VALUE IN HEALTH, 2020, 23 : S267 - S267
  • [48] Efficacy of memantine on cognition in mild to moderate Alzheimer's disease
    Pomara, Nunzio
    Ott, Brian R.
    Peskind, Elaine R.
    Resnick, E. M.
    ANNALS OF NEUROLOGY, 2006, 60 : S6 - S6
  • [49] Economic impact of galantamine in mild to moderate Alzheimer's disease
    Caro, J
    Migliaccio-Walle, K
    Ishak, KJ
    Getsios, D
    O'Brien, JA
    Papadopoulos, G
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S79 - S79
  • [50] Improving drug trials for mild to moderate Alzheimer's disease
    Hogan, David B.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 : S97 - S102
12345